Lincomycin 300 mg per 1mL Injection

Description

Lincomycin 3,000 mg per 10 mL Injection

Lincomycin Injection is a prescription antibiotic supplied as a sterile solution for injection. The 3,000 mg per 10 mL presentation contains 300 mg of lincomycin per mL, equivalent to 340 mg/mL of lincomycin hydrochloride. It is available as a 10 mL multiple-dose vial in certain markets. The manufacturer and exact product presentation should be confirmed against the supplied pack.

Uses of Lincomycin

• Used to treat certain serious bacterial infections caused by susceptible microorganisms.
• May be prescribed for selected infections when appropriate alternative antibiotics are unsuitable, according to clinical guidance.
• Treatment selection depends on the type of infection, laboratory findings, patient condition, and local prescribing recommendations.

Benefits of Lincomycin in Treatment

• Provides antibacterial activity against susceptible bacteria.
• Offers a parenteral treatment option for selected serious bacterial infections.
• Can be considered by healthcare professionals when clinically appropriate based on the infection and susceptibility results.
• Supports targeted antibiotic treatment when prescribed according to approved guidelines.

Side Effects of Lincomycin

Possible side effects include:

• Diarrhea, nausea, or vomiting
• Abdominal discomfort
• Skin rash or itching
• Changes in blood cell counts
• Abnormal liver function tests
• Injection-site reactions

Important safety warning: Lincomycin may cause severe antibiotic-associated diarrhea and potentially life-threatening inflammation of the colon. Seek prompt medical attention for severe, persistent, or bloody diarrhea, including symptoms that develop after treatment has ended. Serious allergic reactions can also occur.

Quick Tips

• Use only with a valid prescription and under the supervision of a qualified healthcare professional.
• The dose and duration depend on the infection, patient factors, and clinical assessment.
• Intravenous administration requires appropriate dilution and administration by trained healthcare professionals, according to the product instructions.
• Do not self-administer or use leftover antibiotics.
• Inform the healthcare professional about allergies to antibiotics, previous antibiotic-associated colitis, and other medicines being taken.
• Store according to the exact manufacturer’s label. Some US-labelled presentations specify controlled room temperature of 20°C–25°C; verify the storage instructions for the product supplied.
• Complete treatment as prescribed and report serious or unexpected side effects promptly.

To Order : oder@srkpharma.com

Patient Assistance Program (PAP) or Patient Named Program : We also support Patient Assistance Programs (PAPs) and Patient Named Programs, helping eligible patients access required medicines through a patient-focused and streamlined process. We support patients and healthcare partners with product sourcing, documentation, order coordination, and delivery assistance, subject to applicable program requirements and country regulations.  We support medicine supply through PAP and Patient Named Programs across countries including the USA, UK, Canada, Australia, India, Brazil, Nigeria, South Africa, UAE, Saudi Arabia, Germany, France, Italy, Spain, Singapore, Malaysia, and other international markets. Our goal is to make access to essential medicines simpler, reliable, and patient-focused, while supporting patients and healthcare partners throughout the supply process.